机器人平台和新设备在HPB手术中的应用：一项欧洲-非洲肝-胰-胆协会（E-AHPBA）调查。

IF 2.4 3区医学 Q2 GASTROENTEROLOGY & HEPATOLOGY

Hpb Pub Date : 2025-09-05 DOI:10.1016/j.hpb.2025.09.001

Matteo De Pastena, Salvatore Paiella, Gabriella Lionetto, Francesca Ratti, Gregor A Stavrou, Andrew J Healey, Niki Rashidian, Andrew A Gumbs, Martina Guerra, Andrea Belli, Aiste Gulla, Alessandro Esposito, Stefan A Bouwense, Angelakoudis Apostolos, Sven A Lang, Victor López-López, Luca Aldrighetti, Oliver Strobel

{"title":"机器人平台和新设备在HPB手术中的应用：一项欧洲-非洲肝-胰-胆协会（E-AHPBA）调查。","authors":"Matteo De Pastena, Salvatore Paiella, Gabriella Lionetto, Francesca Ratti, Gregor A Stavrou, Andrew J Healey, Niki Rashidian, Andrew A Gumbs, Martina Guerra, Andrea Belli, Aiste Gulla, Alessandro Esposito, Stefan A Bouwense, Angelakoudis Apostolos, Sven A Lang, Victor López-López, Luca Aldrighetti, Oliver Strobel","doi":"10.1016/j.hpb.2025.09.001","DOIUrl":null,"url":null,"abstract":"Background/aim: Robotic platforms in Hepato-Pancreato-Biliary (HPB) surgery improved surgical precision and recovery. However, their adoption remains inconsistent. This study aims to assess the current status of robotic surgery in HPB procedures.Methods: The Innovation Committee of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA) developed a web-based survey. The survey collected data from 82 European and African centers on the availability, usage, and surgical volumes of robotic platforms in liver and pancreatic resections. Descriptive statistics were used to analyze responses.Results: The survey found that 94% (77/82) of centers use robotic platforms for HPB surgery, but only 6% (5/82) rely solely on robotic systems. The Da Vinci Surgical System was the most commonly used platform, present in 88% (72/82) of centers. Regarding surgical volumes, 62% (51/82) of centers perform at least 20 robot-assisted liver resections annually, whereas only 2% (2/82) exceed 80 procedures. In pancreatic surgery, 28% (23/82) of centers do not utilize robotic platforms. Additionally, 37% (30/82) of centers perform fewer than 10 robot-assisted HPB resections per year. Conversely, 38% (31/82) report using robotic platforms 2-3 days per week.Discussion: Robotic platforms are increasingly incorporated into HPB surgery. However, their widespread adoption is limited by economic, logistical, and utilization constraints.","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diffusion of robotic platforms and new devices in HPB surgery: a European-African Hepato-Pancreato-Biliary Association (E-AHPBA) survey.\",\"authors\":\"Matteo De Pastena, Salvatore Paiella, Gabriella Lionetto, Francesca Ratti, Gregor A Stavrou, Andrew J Healey, Niki Rashidian, Andrew A Gumbs, Martina Guerra, Andrea Belli, Aiste Gulla, Alessandro Esposito, Stefan A Bouwense, Angelakoudis Apostolos, Sven A Lang, Victor López-López, Luca Aldrighetti, Oliver Strobel\",\"doi\":\"10.1016/j.hpb.2025.09.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background/aim: Robotic platforms in Hepato-Pancreato-Biliary (HPB) surgery improved surgical precision and recovery. However, their adoption remains inconsistent. This study aims to assess the current status of robotic surgery in HPB procedures.Methods: The Innovation Committee of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA) developed a web-based survey. The survey collected data from 82 European and African centers on the availability, usage, and surgical volumes of robotic platforms in liver and pancreatic resections. Descriptive statistics were used to analyze responses.Results: The survey found that 94% (77/82) of centers use robotic platforms for HPB surgery, but only 6% (5/82) rely solely on robotic systems. The Da Vinci Surgical System was the most commonly used platform, present in 88% (72/82) of centers. Regarding surgical volumes, 62% (51/82) of centers perform at least 20 robot-assisted liver resections annually, whereas only 2% (2/82) exceed 80 procedures. In pancreatic surgery, 28% (23/82) of centers do not utilize robotic platforms. Additionally, 37% (30/82) of centers perform fewer than 10 robot-assisted HPB resections per year. Conversely, 38% (31/82) report using robotic platforms 2-3 days per week.Discussion: Robotic platforms are increasingly incorporated into HPB surgery. However, their widespread adoption is limited by economic, logistical, and utilization constraints.\",\"PeriodicalId\":13229,\"journal\":{\"name\":\"Hpb\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-09-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hpb\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.hpb.2025.09.001\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hpb","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.hpb.2025.09.001","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

背景/目的：机器人平台在肝胰胆（HPB）手术中提高了手术精度和恢复。然而，它们的采用仍然不一致。本研究旨在评估机器人手术在HPB手术中的现状。方法：欧洲-非洲肝胆协会创新委员会（E-AHPBA）开展了一项基于网络的调查。该调查收集了82个欧洲和非洲中心关于机器人平台在肝脏和胰腺切除术中的可用性、使用情况和手术量的数据。采用描述性统计分析反应。结果：调查发现94%（77/82）的中心使用机器人平台进行HPB手术，但只有6%（5/82）的中心完全依赖机器人系统。达芬奇手术系统是最常用的平台，88%（72/82）的中心使用。就手术量而言，62%（51/82）的中心每年至少进行20例机器人辅助肝脏切除术，而只有2%（2/82）的中心超过80例手术。在胰腺手术中，28%（23/82）的中心没有使用机器人平台。此外，37%（30/82）的中心每年进行的机器人辅助HPB切除术少于10例。相反，38%（31/82）的受访者表示每周使用机器人平台2-3天。讨论：机器人平台越来越多地应用于HPB手术。然而，它们的广泛采用受到经济、后勤和使用限制的限制。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Diffusion of robotic platforms and new devices in HPB surgery: a European-African Hepato-Pancreato-Biliary Association (E-AHPBA) survey.

Background/aim: Robotic platforms in Hepato-Pancreato-Biliary (HPB) surgery improved surgical precision and recovery. However, their adoption remains inconsistent. This study aims to assess the current status of robotic surgery in HPB procedures.

Methods: The Innovation Committee of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA) developed a web-based survey. The survey collected data from 82 European and African centers on the availability, usage, and surgical volumes of robotic platforms in liver and pancreatic resections. Descriptive statistics were used to analyze responses.

Results: The survey found that 94% (77/82) of centers use robotic platforms for HPB surgery, but only 6% (5/82) rely solely on robotic systems. The Da Vinci Surgical System was the most commonly used platform, present in 88% (72/82) of centers. Regarding surgical volumes, 62% (51/82) of centers perform at least 20 robot-assisted liver resections annually, whereas only 2% (2/82) exceed 80 procedures. In pancreatic surgery, 28% (23/82) of centers do not utilize robotic platforms. Additionally, 37% (30/82) of centers perform fewer than 10 robot-assisted HPB resections per year. Conversely, 38% (31/82) report using robotic platforms 2-3 days per week.

Discussion: Robotic platforms are increasingly incorporated into HPB surgery. However, their widespread adoption is limited by economic, logistical, and utilization constraints.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Hpb GASTROENTEROLOGY & HEPATOLOGY-SURGERY

CiteScore

5.60

自引率

3.40%

发文量

244

审稿时长

57 days

期刊介绍： HPB is an international forum for clinical, scientific and educational communication. Twelve issues a year bring the reader leading articles, expert reviews, original articles, images, editorials, and reader correspondence encompassing all aspects of benign and malignant hepatobiliary disease and its management. HPB features relevant aspects of clinical and translational research and practice. Specific areas of interest include HPB diseases encountered globally by clinical practitioners in this specialist field of gastrointestinal surgery. The journal addresses the challenges faced in the management of cancer involving the liver, biliary system and pancreas. While surgical oncology represents a large part of HPB practice, submission of manuscripts relating to liver and pancreas transplantation, the treatment of benign conditions such as acute and chronic pancreatitis, and those relating to hepatobiliary infection and inflammation are also welcomed. There will be a focus on developing a multidisciplinary approach to diagnosis and treatment with endoscopic and laparoscopic approaches, radiological interventions and surgical techniques being strongly represented. HPB welcomes submission of manuscripts in all these areas and in scientific focused research that has clear clinical relevance to HPB surgical practice. HPB aims to help its readers - surgeons, physicians, radiologists and basic scientists - to develop their knowledge and practice. HPB will be of interest to specialists involved in the management of hepatobiliary and pancreatic disease however will also inform those working in related fields. Abstracted and Indexed in: MEDLINE® EMBASE PubMed Science Citation Index Expanded Academic Search (EBSCO) HPB is owned by the International Hepato-Pancreato-Biliary Association (IHPBA) and is also the official Journal of the American Hepato-Pancreato-Biliary Association (AHPBA), the Asian-Pacific Hepato Pancreatic Biliary Association (A-PHPBA) and the European-African Hepato-Pancreatic Biliary Association (E-AHPBA).